𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses

✍ Scribed by Ioannis Panagopoulos; Fredrik Mertens; Maria Dêbiec-Rychter; Margareth Isaksson; Janusz Limon; Iwona Kardas; Henryk A. Domanski; Raf Sciot; Danuta Perek; Sead Crnalic; Olle Larsson; Nils Mandahl


Publisher
John Wiley and Sons
Year
2002
Tongue
French
Weight
558 KB
Volume
99
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Clear cell sarcoma (CCS) is a rare malignant soft tissue tumor particularly associated with tendons and aponeuroses. The cytogenetic hallmark is the translocation t(12;22)(q13;q12) resulting in a chimeric EWS/ATF1 gene in which the 3′‐terminal part of EWS at 22q is replaced by the 3′‐terminal part of ATF1 at 12q. To date, only 13 cases of CCS have been analyzed for fusion genes at the transcription level, and there is no information about the breakpoints at the genomic level. In the present study, we describe the molecular genetic characteristics of CCS from 10 patients. Karyotypes were obtained from 10 cases, 7 of which showed the characteristic t(12;22). As an initial step in the characterization of the EWS/ATF1 and ATF1/EWS chimeras, we constructed an exon/intron map of the ATF1 gene. The entire ATF1 gene spanned >40 kb and was composed of 7 exons. Intron 3, in which most of the genomic breakpoints occurred, was to a large extent (83%) composed of repetitive elements. RT‐PCR amplified EWS/ATF1 cDNA fragments in all patients and ATF1/EWS cDNA fragments in 6 of 10 patients. Four types of EWS/ATF1 chimeric transcript, designated types 1–4, were identified. The most frequent chimeric transcript (type 1) was an in‐frame fusion of exon 8 of EWS with exon 4 of ATF1. This was the only chimeric transcript in 5 patients but found together with other variants in 3 tumors. The type 2 transcript of EWS/ATF1, an in‐frame fusion of exon 7 of EWS with exon 5 of ATF1, was detected in 4 patients, as the only transcript in 1 case and together with other variants in 3 cases. An in‐frame fusion of exon 10 of EWS with exon 5 of ATF1 (type 3) was found in 1 patient as the only transcript, and an out‐of‐frame fusion of EWS exon 7 with ATF1 exon 7 (type 4) was detected in 1 patient together with type 1 and type 2 transcripts. Sequencing of the amplified ATF1/EWS cDNA fragments showed in 5 patients that ATF1 exon 3 was fused with EWS exon 10, resulting in an out‐of‐frame chimeric transcript. In 1 case, nt 428 of ATF1 (exon 4) was fused with EWS exon 8; at the junction, there was an insertion of 4 nucleotides, also resulting in an out‐of‐frame transcript. Genomic extra long PCR and sequence analysis mapped the genomic breakpoints to introns 7, 8 and 9 of EWS and intron 3 and exon 4 of ATF1. While a simple end‐to‐end fusion was observed in 2 cases, additional nucleotides were found at the junctions in 2 other cases. In addition, topoisomerase I consensus sequences were found close to the junctions, suggesting that this enzyme may participate in the genesis of the EWS/ATF1 fusion. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


New type of chimeric fusion product betw
✍ Antonio Pellín; Carlos Monteagudo; Concha López-Ginés; Carmen Carda; Javier Boix 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

We report a new case of clear cell sarcoma (CCS) harboring the t(12;22)(q13;q12). Reverse transcription-polymerase chain reaction (RT-PCR) analysis revealed the presence of a chimeric transcript between the EWS and ATF1 genes, both in primary and metastatic tissue. Sequencing studies disclosed an in

Clear cell sarcoma of tendons and aponeu
✍ Andrea Ferrari; Michela Casanova; Gianni Bisogno; Adrian Mattke; Cristina Meazza 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Abstract ## BACKGROUND Clear cell sarcoma (CCS) of tendons and aponeuroses is extremely rare in childhood and little information is available on its clinical management. Originally believed to be a type of melanoma of soft tissue origin, CCS is now considered a distinct clinicopathologic entity

Further characterization of the human cl
✍ Sonobe, Hiroshi; Takeuchi, Tamotsu; Taguchi, Takahiro; Shimizu, Kiichi; Iwata, J 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

Only a small number of clear cell sarcoma (CCS) cell lines have been reported, including the cell line HS-MM. In the present study, this cell line, maintained for more than 4 years since establishment, was further characterized by cytogenetic studies, fluorescence in situ hybridization (FISH) analys

The 12q13-q15 translocation breakpoints
✍ Dr. Göran Stenman; Pelle Sahlin; Joachim Mark; R. S. K. Chaganti; Lars-Gunnar Ki 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

The transcription factor gene CHOP was recently shown to be rearranged in myxoid liposarcoma with t( 12; I6)(q I );p I I). We have analyzed whether the CHOP gene is the target of rearrangements in pleomorphic adenoma and clear-cell sarcoma of tendons and aponeuroses with chromosome abnormalities of

Molecular genetic characterization of th
✍ Ioannis Panagopoulos; Fredrik Mertens; Margareth Isaksson; Henryk A. Domanski; O 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB

## Abstract Extraskeletal myxoid chondrosarcoma (EMC) is a soft‐tissue neoplasm cytogenetically characterized by the translocations t(9;22)(q22;q11–12) or t(9;17)(q22;q11), generating __EWS/CHN__ or __RBP56/CHN__ fusion genes, respectively. In the present study, 18 EMCs were studied both cytogeneti

Frequent fusion of the CRTC1 and MAML2 g
✍ Marta Winnes; Lena Mölne; Mart Suurküla; Ywonne Andrén; Fredrik Persson; Fredrik 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

## Abstract Fusion of the CREB regulated transcription coactivator CRTC1 (a.k.a. MECT1, TORC1, or WAMTP1) to the Notch coactivator MAML2 is a characteristic feature of low‐grade mucoepidermoid carcinomas of salivary and bronchial glands. The CRTC1–MAML2 fusion protein acts by inducing transcription